Forward Pharma A/S is a biotechnology company. It is focused on the immunomodulatory compound dimethyl fumarate and derivatives, for applications as a pharmaceutical drug product to treat immune disorders such as multiple sclerosis and psoriasis. The Company is advancing its lead drug candidate FP187 for possible treatment of immune disorders including multiple sclerosis and psoriasis. Forward Pharma A/S is headquartered in Copenhagen, Denmark.